Seven Bridges and Station X Launch Fully-Integrated, Cloud-Based Genomic Analysis Solution
News Apr 23, 2015
Seven Bridges Genomics, Inc. and Station X, Inc. have completed the integration of their respective platforms for researchers and clinicians seeking a seamless, end-to-end solution for scalable genomic data management, storage and analysis.
The Seven Bridges Genomics (SBG) Platform provides an integrated environment to manage any next generation sequencing data analysis workflow — from raw data through compute and storage intensive data processing protocols to usable, interpretable data. GenePool, from Station X, allows researchers to securely manage, visualize, and analyze processed genomic data from one to thousands of patients and then, securely share the data and resulting knowledge with colleagues. Together, the two platforms enable customers to perform the rapid interrogation of patient-derived sequencing data, and their associated clinical and sample metadata, in a secure and interactive way.
"The Seven Bridges Platform provides an integrated environment to manage, execute and collaborate on all aspects of sequencing analysis workflows,” said Seven Bridges Genomics CEO Deniz Kural. “We are pleased to integrate with GenePool to provide our mutual customers an easy way to go from their Seven Bridges analysis to exploration with Station X."
“GenePool was designed to accelerate the identification and validation of biomarkers that play a role in human disease and the translation of these findings into actionable results,” said Richard Goold, CEO of Station X. “Through our collaboration with Seven Bridges Genomics, we can now provide our mutual customers with a complete solution that will allow them to manage the entire process from sample to answer – with one fully integrated, cloud-based solution.”
The integrated workflow has been in pre-release testing at selected cancer genomics research laboratories and academic centers in North America. “Our customers have now processed a number of valuable and interesting datasets related to various cancers through the combined Seven Bridges / GenePool solution. They find the integrated software to be easy-to-use, robust and very informative” said Tod Klingler, CSO of Station X.
The integrated solution is available via either Seven Bridges Genomics or Station X, each of whom will each maintain responsibility for technical support and maintenance of their respective platforms.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE